A review of the neurobiological underpinning of comorbid substance use and mood disorders

被引:31
|
作者
Gomez-Coronado, Nieves [1 ,9 ]
Sethi, Rickinder [2 ]
Bortolasci, Chiara Cristina [3 ]
Arancini, Lauren [4 ]
Berk, Michael [4 ,5 ,6 ,7 ,8 ]
Dodd, Seetal [4 ,5 ,6 ,7 ]
机构
[1] Hosp Univ Virgen del Rocio, Unidad Gest Clin Salud Mental, Seville, Spain
[2] Western Univ, London Hlth Sci Ctr, London, ON, Canada
[3] Deakin Univ, Sch Med, Ctr Mol & Med Res, Geelong, Vic, Australia
[4] Deakin Univ, IMPACT Strateg Res Ctr, Geelong, Vic, Australia
[5] Univ Hosp Geelong, Barwon Hlth, Geelong, Vic, Australia
[6] Univ Melbourne, Dept Psychiat, Parkville, Vic, Australia
[7] Natl Ctr Excellence Youth Mental Hlth, Orygen, Parkville, Vic, Australia
[8] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia
[9] Hosp San Agustin ORL, Dept Psychiat, Seville, Spain
基金
英国医学研究理事会;
关键词
Neurobiology; Dual diagnosis; Glutamate; Dopamine; Oxidative stress; Inflammation; MAJOR DEPRESSIVE DISORDER; ALCOHOL-USE DISORDERS; GRAM-NEGATIVE ENTEROBACTERIA; PARAOXONASE (PON)1 ACTIVITY; SELF-MEDICATION HYPOTHESIS; INCREASED OXIDATIVE STRESS; GAMMA-AMINOBUTYRIC-ACID; C-REACTIVE PROTEIN; BIPOLAR DISORDER; INFLAMMATORY MARKERS;
D O I
10.1016/j.jad.2018.08.041
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: There is evidence that substance use disorders and other mental disorders may have shared biological mechanisms. However, the neurobiological basis of this comorbidity remains only partially explained. This review describes the historical evolution of the dual disorders concept and approach, and reviews the existing literature on neurobiological findings specifically regarding comorbid substance use and mood disorders. Methods: Searches were conducted using PubMed and Scopus in December 2017. A Boolean search was performed using combinations of "dual diagnosis" or "dual disorder" or "depression" or "bipolar" or "affective disorder" or "mood disorder" and "substance use" or "substance abuse" and "neurobiology" or "functional neuroimaging" or "genetics" or "neurotransmitters" or "neuroendocrinology" in the title or abstract, or as keywords, using no language restriction, Results: 32 studies met the inclusion criteria. We found robust evidence for involvement of the neurotransmitters dopamine, GABA and glutamate and their receptors, as well as by the central corticotrophin-releasing hormone, hypothalamic pituitary adrenal axis activation, oxidative stress and inflammation. Recent studies focusing on neuroimaging and genetics have not shown consistent results. Limitations: Only two search tools were used; most identified studies excluded the population of interest (comorbid mood and substance abuse disorders). Conclusions: The neurobiological relevance for the occurrence of comorbid mood and substance abuse disorders has not been fully elucidated. Considering the high levels of individuals who experience comorbidity in these areas as well as the negative associated outcomes, this is clearly an area that requires further in-depth investigation. Furthermore, findings from this area can help to inform drug abuse prevention and intervention efforts, and especially how they relate to populations with psychiatric symptoms.
引用
收藏
页码:388 / 401
页数:14
相关论文
共 50 条
  • [1] Pharmacotherapy of comorbid mood, anxiety, and substance use disorders
    Brady, KT
    Verduin, ML
    [J]. SUBSTANCE USE & MISUSE, 2005, 40 (13-14) : 2021 - 2041
  • [2] Neurobiological underpinnings and modulating factors in schizophrenia spectrum disorders with a comorbid substance use disorder: A systematic review
    Adan, Ana
    Arredondo, Arantxa Y.
    del Mar Capella, Maria
    Prat, Gemma
    Forero, Diego A.
    Francisco Navarro, Jose
    [J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2017, 75 : 361 - 377
  • [3] Substance use disorders comorbid with mood and anxiety disorders in the Australian general population
    Prior, Katrina
    Mills, Katherine
    Ross, Joanne
    Teesson, Maree
    [J]. DRUG AND ALCOHOL REVIEW, 2017, 36 (03) : 317 - 324
  • [4] Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders
    Liraud, F
    Verdoux, H
    [J]. ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2002, 28 (02): : 160 - 168
  • [5] Secular trends in first hospitalizations for major mood disorders with comorbid substance use
    Minnai, Gian Paolo
    Tondo, Leonardo
    Salis, Piergiorgio
    Ghiani, Carmen
    Manfredi, Andrea
    Paluello, Michela M.
    Baethge, Christopher
    Baldessarini, Ross J.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 (03): : 319 - 326
  • [6] Chronic pain and comorbid mood and substance use disorders: A biopsychosocial treatment approach
    Cheatle M.D.
    Gallagher R.M.
    [J]. Current Psychiatry Reports, 2006, 8 (5) : 371 - 376
  • [7] Treatment for Outpatients with Comorbid Schizophrenia and Substance Use Disorders: A Review
    De Witte, Nele A. J.
    Crunelle, Cleo L.
    Sabbe, Bernard
    Moggi, Franz
    Dom, Geert
    [J]. EUROPEAN ADDICTION RESEARCH, 2014, 20 (03) : 105 - 114
  • [8] Substance use disorders and personality disorders. Review from a neurobiological and psychodynamic perspective
    Walter, Marc
    Dammann, Gerhard
    [J]. PSYCHOTHERAPEUT, 2012, 57 (05): : 425 - +
  • [9] Efficacy of Pharmacotherapy for Comorbid Major Depression and Substance Use Disorders: A review
    Salloum, Ihsan M.
    Jones, Yemisi Olagunju
    [J]. CURRENT PSYCHIATRY REVIEWS, 2008, 4 (01) : 14 - 27
  • [10] The effect of comorbid substance use disorders on the course of bipolar disorder: A review
    Tohen, M
    Greenfield, SF
    Weiss, RD
    Zarate, CA
    Vagge, LM
    [J]. HARVARD REVIEW OF PSYCHIATRY, 1998, 6 (03) : 133 - 141